These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 17467763

  • 1. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?
    O'Leary MA, Schneider JJ, Krishnan BP, Lavis C, McKendry A, Ong LK, Isbister GK.
    Toxicon; 2007 Aug; 50(2):206-13. PubMed ID: 17467763
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
    Lane J, O'Leary MA, Isbister GK.
    Toxicon; 2011 Sep 01; 58(3):239-46. PubMed ID: 21723878
    [Abstract] [Full Text] [Related]

  • 6. Commercial monovalent antivenoms in Australia are polyvalent.
    O'Leary MA, Isbister GK.
    Toxicon; 2009 Aug 01; 54(2):192-5. PubMed ID: 19375442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, Lincz LF.
    Toxicon; 2010 Aug 01; 56(1):75-85. PubMed ID: 20338189
    [Abstract] [Full Text] [Related]

  • 10. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
    Zdenek CN, den Brouw BO, Dashevsky D, Gloria A, Youngman NJ, Watson E, Green P, Hay C, Dunstan N, Allen L, Fry BG.
    Toxicol Lett; 2019 Nov 01; 316():171-182. PubMed ID: 31442586
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR, Vassão RC, de Roodt AR, Santos E Silva EC, Mirtschin P, Ho PL, Spencer PJ.
    Clin Toxicol (Phila); 2017 Jan 01; 55(1):33-39. PubMed ID: 27595162
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of immunoturbidimetry to detect venom-antivenom binding using snake venoms.
    O'Leary MA, Maduwage K, Isbister GK.
    J Pharmacol Toxicol Methods; 2013 Jan 01; 67(3):177-81. PubMed ID: 23416032
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antivenom efficacy or effectiveness: the Australian experience.
    Isbister GK.
    Toxicology; 2010 Feb 09; 268(3):148-54. PubMed ID: 19782716
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA, Isbister GK.
    Toxicon; 2014 Jan 09; 77():125-32. PubMed ID: 24252422
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.